A person must also be at least 18 years old and meet one of the following criteria: Have a body mass index (BMI) of at least 35 at the time they begin the GLP-1 medication Have a BMI of at least 30 at the time of beginning the medication and at least one of the following diagnoses: Heart failure with preserved ejection fraction Uncontrolled hypertension Chronic kidney disease (stage 3a or above) Have a BMI of at least 27 at the time of beginning the medication and at least one of the following diagnoses: Pre-diabetes Previous heart attack Previous stroke Symptomatic peripheral artery disease Anyone who meets these qualifications but is eligible to receive GLP-1 coverage under Part D for another condition, like type 2 diabetes, wont qualify for the Bridge program, CMS says
Also, chronic receptor start may lead to receptor downregulation or desensitization, phenomena that are important factors in research protocol design
Literature Search Strategy A comprehensive literature search was conducted on Medline, Embase, Emcare, The University of Melbourne full-text journals repository, Google Scholar and Evidence-Based Medicine (EBM) reviews (including the following databases
Progress Tracking : Comprehensive monitoring of weight loss, body composition changes, health improvements, and quality of life enhancements